Fmc-Balboa East County in El Cajon, California - Dialysis Center

Fmc-Balboa East County is a medicare approved dialysis facility center in El Cajon, California and it has 24 dialysis stations. It is located in San Diego county at 570 N. Second Street, El Cajon, CA, 92021. You can reach out to the office of Fmc-Balboa East County at (619) 588-7500. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Fmc-Balboa East County has the following ownership type - Profit. It was first certified by medicare in February, 1996. The medicare id for this facility is 052780 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameFmc-Balboa East County
Location570 N. Second Street, El Cajon, California
No. of Dialysis Stations 24
Medicare ID052780
Managed ByFresenius Medical Care
Ownership TypeProfit
Late Shifts No

Contact Information


570 N. Second Street, El Cajon, California, 92021
(619) 588-7500

News Archive

Drinking piping hot beverages may increase risk of esophagus tumors

Drinking piping hot coffee, tea and the caffeine-infused beverage yerba mate probably causes cancer, the World Health Organization announced Wednesday.

Denosumab effective in treating giant-cell tumor of the bone

Treatment with denosumab, a drug targeted against a protein that helps promote bone destruction, decreased the number of tumor giant cells in patients with giant-cell tumor of the bone, and increased new bone formation, according to the results of a phase II study published in Clinical Cancer Research, a journal of the American Association for Cancer Research.

MDI adds McKesson's CareEnhance Disease Monitor software to Viewpoint Analytics solutions portfolio

MDI announced today that it has added McKesson's CareEnhance® Disease Monitor software to the Viewpoint Analytics solutions portfolio. Integrating one of the industry's leading disease management products increases the breadth of solutions available from Viewpoint Analytics.

Study: Pradaxa drug may increase risk and severity of viral infections

A study led by researchers at the University of North Carolina indicates that a newly approved blood thinner that blocks a key component of the human blood clotting system may increase the risk and severity of certain viral infections, including flu and myocarditis, a viral infection of the heart and a significant cause of sudden death in children and young adults.

Read more Medical News

› Verified 8 days ago


Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Fmc-Balboa East County from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1003928805
Organization NameEast County Dialysis Center
Doing Business AsSan Diego Dialysis Services, Inc.
Address570 N 2nd St El Cajon, California, 92021
Phone Number(619) 588-7500

News Archive

Drinking piping hot beverages may increase risk of esophagus tumors

Drinking piping hot coffee, tea and the caffeine-infused beverage yerba mate probably causes cancer, the World Health Organization announced Wednesday.

Denosumab effective in treating giant-cell tumor of the bone

Treatment with denosumab, a drug targeted against a protein that helps promote bone destruction, decreased the number of tumor giant cells in patients with giant-cell tumor of the bone, and increased new bone formation, according to the results of a phase II study published in Clinical Cancer Research, a journal of the American Association for Cancer Research.

MDI adds McKesson's CareEnhance Disease Monitor software to Viewpoint Analytics solutions portfolio

MDI announced today that it has added McKesson's CareEnhance® Disease Monitor software to the Viewpoint Analytics solutions portfolio. Integrating one of the industry's leading disease management products increases the breadth of solutions available from Viewpoint Analytics.

Study: Pradaxa drug may increase risk and severity of viral infections

A study led by researchers at the University of North Carolina indicates that a newly approved blood thinner that blocks a key component of the human blood clotting system may increase the risk and severity of certain viral infections, including flu and myocarditis, a viral infection of the heart and a significant cause of sudden death in children and young adults.

Read more Medical News

› Verified 8 days ago


NPI Number1962839183
Organization NameFresenius Medical Care Balboa East County
Doing Business AsFresenius Medical Care Balboa Ii, Llc
Address570 N 2nd St El Cajon, California, 92021
Phone Number(619) 588-7500

News Archive

Drinking piping hot beverages may increase risk of esophagus tumors

Drinking piping hot coffee, tea and the caffeine-infused beverage yerba mate probably causes cancer, the World Health Organization announced Wednesday.

Denosumab effective in treating giant-cell tumor of the bone

Treatment with denosumab, a drug targeted against a protein that helps promote bone destruction, decreased the number of tumor giant cells in patients with giant-cell tumor of the bone, and increased new bone formation, according to the results of a phase II study published in Clinical Cancer Research, a journal of the American Association for Cancer Research.

MDI adds McKesson's CareEnhance Disease Monitor software to Viewpoint Analytics solutions portfolio

MDI announced today that it has added McKesson's CareEnhance® Disease Monitor software to the Viewpoint Analytics solutions portfolio. Integrating one of the industry's leading disease management products increases the breadth of solutions available from Viewpoint Analytics.

Study: Pradaxa drug may increase risk and severity of viral infections

A study led by researchers at the University of North Carolina indicates that a newly approved blood thinner that blocks a key component of the human blood clotting system may increase the risk and severity of certain viral infections, including flu and myocarditis, a viral infection of the heart and a significant cause of sudden death in children and young adults.

Read more Medical News

› Verified 8 days ago


Survey of Patient's Experiences

Nephrologists Performance Ratings

Experience MeasureProviderNational Avg.
Patients who reported that nephrologists always communicated and cared for them.58%67%
Patients who reported that nephrologists usually communicated and cared for them.13%15%
Patients who reported that nephrologists sometimes or never communicated and cared for them.29%18%
Patients who gave their nephrologists a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible).45%60%
Patients who gave their nephrologists a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible).30%26%
Patients who gave their nephrologists a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible).25%14%

News Archive

Drinking piping hot beverages may increase risk of esophagus tumors

Drinking piping hot coffee, tea and the caffeine-infused beverage yerba mate probably causes cancer, the World Health Organization announced Wednesday.

Denosumab effective in treating giant-cell tumor of the bone

Treatment with denosumab, a drug targeted against a protein that helps promote bone destruction, decreased the number of tumor giant cells in patients with giant-cell tumor of the bone, and increased new bone formation, according to the results of a phase II study published in Clinical Cancer Research, a journal of the American Association for Cancer Research.

MDI adds McKesson's CareEnhance Disease Monitor software to Viewpoint Analytics solutions portfolio

MDI announced today that it has added McKesson's CareEnhance® Disease Monitor software to the Viewpoint Analytics solutions portfolio. Integrating one of the industry's leading disease management products increases the breadth of solutions available from Viewpoint Analytics.

Study: Pradaxa drug may increase risk and severity of viral infections

A study led by researchers at the University of North Carolina indicates that a newly approved blood thinner that blocks a key component of the human blood clotting system may increase the risk and severity of certain viral infections, including flu and myocarditis, a viral infection of the heart and a significant cause of sudden death in children and young adults.

Read more Medical News

› Verified 8 days ago

Dialysis Center Staff Performance Ratings

Experience MeasureProviderNational Avg.
Patients who reported that dialysis center staff always communicated well, kept patients comfortable and pain-free as possible.62%62%
Patients who reported that dialysis center staff usually communicated, kept patients comfortable and pain-free as possible.18%20%
Patients who reported that dialysis center staff sometimes or never communicated, kept patients comfortable and pain-free.20%18%
Patients who gave their dialysis facility staff a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible).52%62%
Patients who gave their dialysis facility staff a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible).32%26%
Patients who gave their dialysis facility staff a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible).16%12%

News Archive

Drinking piping hot beverages may increase risk of esophagus tumors

Drinking piping hot coffee, tea and the caffeine-infused beverage yerba mate probably causes cancer, the World Health Organization announced Wednesday.

Denosumab effective in treating giant-cell tumor of the bone

Treatment with denosumab, a drug targeted against a protein that helps promote bone destruction, decreased the number of tumor giant cells in patients with giant-cell tumor of the bone, and increased new bone formation, according to the results of a phase II study published in Clinical Cancer Research, a journal of the American Association for Cancer Research.

MDI adds McKesson's CareEnhance Disease Monitor software to Viewpoint Analytics solutions portfolio

MDI announced today that it has added McKesson's CareEnhance® Disease Monitor software to the Viewpoint Analytics solutions portfolio. Integrating one of the industry's leading disease management products increases the breadth of solutions available from Viewpoint Analytics.

Study: Pradaxa drug may increase risk and severity of viral infections

A study led by researchers at the University of North Carolina indicates that a newly approved blood thinner that blocks a key component of the human blood clotting system may increase the risk and severity of certain viral infections, including flu and myocarditis, a viral infection of the heart and a significant cause of sudden death in children and young adults.

Read more Medical News

› Verified 8 days ago

Overall Dialysis Center Performance Ratings

Experience MeasureProviderNational Avg.
Patients who reported that 'YES', their nephrologists and dialysis center staff provided them the information they needed to take care of them. 80%80%
Patients who reported that 'NO', their nephrologists and dialysis center staff does not provided them the information they needed to take care of them.20%20%
Patients who gave their dialysis center a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible).54%68%
Patients who gave their dialysis center a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible).27%20%
Patients who gave their dialysis center a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible).19%12%

News Archive

Drinking piping hot beverages may increase risk of esophagus tumors

Drinking piping hot coffee, tea and the caffeine-infused beverage yerba mate probably causes cancer, the World Health Organization announced Wednesday.

Denosumab effective in treating giant-cell tumor of the bone

Treatment with denosumab, a drug targeted against a protein that helps promote bone destruction, decreased the number of tumor giant cells in patients with giant-cell tumor of the bone, and increased new bone formation, according to the results of a phase II study published in Clinical Cancer Research, a journal of the American Association for Cancer Research.

MDI adds McKesson's CareEnhance Disease Monitor software to Viewpoint Analytics solutions portfolio

MDI announced today that it has added McKesson's CareEnhance® Disease Monitor software to the Viewpoint Analytics solutions portfolio. Integrating one of the industry's leading disease management products increases the breadth of solutions available from Viewpoint Analytics.

Study: Pradaxa drug may increase risk and severity of viral infections

A study led by researchers at the University of North Carolina indicates that a newly approved blood thinner that blocks a key component of the human blood clotting system may increase the risk and severity of certain viral infections, including flu and myocarditis, a viral infection of the heart and a significant cause of sudden death in children and young adults.

Read more Medical News

› Verified 8 days ago

Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data91
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL15

News Archive

Drinking piping hot beverages may increase risk of esophagus tumors

Drinking piping hot coffee, tea and the caffeine-infused beverage yerba mate probably causes cancer, the World Health Organization announced Wednesday.

Denosumab effective in treating giant-cell tumor of the bone

Treatment with denosumab, a drug targeted against a protein that helps promote bone destruction, decreased the number of tumor giant cells in patients with giant-cell tumor of the bone, and increased new bone formation, according to the results of a phase II study published in Clinical Cancer Research, a journal of the American Association for Cancer Research.

MDI adds McKesson's CareEnhance Disease Monitor software to Viewpoint Analytics solutions portfolio

MDI announced today that it has added McKesson's CareEnhance® Disease Monitor software to the Viewpoint Analytics solutions portfolio. Integrating one of the industry's leading disease management products increases the breadth of solutions available from Viewpoint Analytics.

Study: Pradaxa drug may increase risk and severity of viral infections

A study led by researchers at the University of North Carolina indicates that a newly approved blood thinner that blocks a key component of the human blood clotting system may increase the risk and severity of certain viral infections, including flu and myocarditis, a viral infection of the heart and a significant cause of sudden death in children and young adults.

Read more Medical News

› Verified 8 days ago

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center166
    Adult patient months included in Kt/V greater than or equal to 1.21553
    Percentage of adult patients getting regular hemodialysis at the center99
    Percentage of pediatric patients getting regular hemodialysis at the center

    News Archive

    Drinking piping hot beverages may increase risk of esophagus tumors

    Drinking piping hot coffee, tea and the caffeine-infused beverage yerba mate probably causes cancer, the World Health Organization announced Wednesday.

    Denosumab effective in treating giant-cell tumor of the bone

    Treatment with denosumab, a drug targeted against a protein that helps promote bone destruction, decreased the number of tumor giant cells in patients with giant-cell tumor of the bone, and increased new bone formation, according to the results of a phase II study published in Clinical Cancer Research, a journal of the American Association for Cancer Research.

    MDI adds McKesson's CareEnhance Disease Monitor software to Viewpoint Analytics solutions portfolio

    MDI announced today that it has added McKesson's CareEnhance® Disease Monitor software to the Viewpoint Analytics solutions portfolio. Integrating one of the industry's leading disease management products increases the breadth of solutions available from Viewpoint Analytics.

    Study: Pradaxa drug may increase risk and severity of viral infections

    A study led by researchers at the University of North Carolina indicates that a newly approved blood thinner that blocks a key component of the human blood clotting system may increase the risk and severity of certain viral infections, including flu and myocarditis, a viral infection of the heart and a significant cause of sudden death in children and young adults.

    Read more Medical News

    › Verified 8 days ago

  • Peritoneal Dialysis
    Adult patients getting regular peritoneal dialysis at the center47
    Adult patient months included in Kt/V greater than or equal to 1.7361
    Percentage of adult patients getting regular peritoneal dialysis at the center95
    Percentage of pediatric patients getting regular peritoneal dialysis at the center

    News Archive

    Drinking piping hot beverages may increase risk of esophagus tumors

    Drinking piping hot coffee, tea and the caffeine-infused beverage yerba mate probably causes cancer, the World Health Organization announced Wednesday.

    Denosumab effective in treating giant-cell tumor of the bone

    Treatment with denosumab, a drug targeted against a protein that helps promote bone destruction, decreased the number of tumor giant cells in patients with giant-cell tumor of the bone, and increased new bone formation, according to the results of a phase II study published in Clinical Cancer Research, a journal of the American Association for Cancer Research.

    MDI adds McKesson's CareEnhance Disease Monitor software to Viewpoint Analytics solutions portfolio

    MDI announced today that it has added McKesson's CareEnhance® Disease Monitor software to the Viewpoint Analytics solutions portfolio. Integrating one of the industry's leading disease management products increases the breadth of solutions available from Viewpoint Analytics.

    Study: Pradaxa drug may increase risk and severity of viral infections

    A study led by researchers at the University of North Carolina indicates that a newly approved blood thinner that blocks a key component of the human blood clotting system may increase the risk and severity of certain viral infections, including flu and myocarditis, a viral infection of the heart and a significant cause of sudden death in children and young adults.

    Read more Medical News

    › Verified 8 days ago

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Fmc-Balboa East County with elevated calcium levels.

Patients with hypercalcemia219
Hypercalcemia patient months2000
Patients with Serumphosphor235
Patients with Serumphosphor less than 3.5 mg/dL10
Patients with Serumphosphor from 3.5 to 4.5 mg/dL25
Patients with Serumphosphor from 4.6 to 5.5 mg/dL26
Patients with Serumphosphor from 5.6 to 7 mg/dL25
Patients with Serumphosphor greater than 7 mg/dL15

News Archive

Drinking piping hot beverages may increase risk of esophagus tumors

Drinking piping hot coffee, tea and the caffeine-infused beverage yerba mate probably causes cancer, the World Health Organization announced Wednesday.

Denosumab effective in treating giant-cell tumor of the bone

Treatment with denosumab, a drug targeted against a protein that helps promote bone destruction, decreased the number of tumor giant cells in patients with giant-cell tumor of the bone, and increased new bone formation, according to the results of a phase II study published in Clinical Cancer Research, a journal of the American Association for Cancer Research.

MDI adds McKesson's CareEnhance Disease Monitor software to Viewpoint Analytics solutions portfolio

MDI announced today that it has added McKesson's CareEnhance® Disease Monitor software to the Viewpoint Analytics solutions portfolio. Integrating one of the industry's leading disease management products increases the breadth of solutions available from Viewpoint Analytics.

Study: Pradaxa drug may increase risk and severity of viral infections

A study led by researchers at the University of North Carolina indicates that a newly approved blood thinner that blocks a key component of the human blood clotting system may increase the risk and severity of certain viral infections, including flu and myocarditis, a viral infection of the heart and a significant cause of sudden death in children and young adults.

Read more Medical News

› Verified 8 days ago

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 135
Patient months included in arterial venous fistula and catheter summaries 1094
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment70
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer2

News Archive

Drinking piping hot beverages may increase risk of esophagus tumors

Drinking piping hot coffee, tea and the caffeine-infused beverage yerba mate probably causes cancer, the World Health Organization announced Wednesday.

Denosumab effective in treating giant-cell tumor of the bone

Treatment with denosumab, a drug targeted against a protein that helps promote bone destruction, decreased the number of tumor giant cells in patients with giant-cell tumor of the bone, and increased new bone formation, according to the results of a phase II study published in Clinical Cancer Research, a journal of the American Association for Cancer Research.

MDI adds McKesson's CareEnhance Disease Monitor software to Viewpoint Analytics solutions portfolio

MDI announced today that it has added McKesson's CareEnhance® Disease Monitor software to the Viewpoint Analytics solutions portfolio. Integrating one of the industry's leading disease management products increases the breadth of solutions available from Viewpoint Analytics.

Study: Pradaxa drug may increase risk and severity of viral infections

A study led by researchers at the University of North Carolina indicates that a newly approved blood thinner that blocks a key component of the human blood clotting system may increase the risk and severity of certain viral infections, including flu and myocarditis, a viral infection of the heart and a significant cause of sudden death in children and young adults.

Read more Medical News

› Verified 8 days ago

Hospitalization Rate

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) YearJanuary, 2016 - December, 2016
Patients in facility's Hospitalization Summary160
Hospitalization Rate in facility183.4 (As Expected)
Hospitalization Rate: Upper Confidence Limit273.3
Hospitalization Rate: Lower Confidence Limit130.7

News Archive

Drinking piping hot beverages may increase risk of esophagus tumors

Drinking piping hot coffee, tea and the caffeine-infused beverage yerba mate probably causes cancer, the World Health Organization announced Wednesday.

Denosumab effective in treating giant-cell tumor of the bone

Treatment with denosumab, a drug targeted against a protein that helps promote bone destruction, decreased the number of tumor giant cells in patients with giant-cell tumor of the bone, and increased new bone formation, according to the results of a phase II study published in Clinical Cancer Research, a journal of the American Association for Cancer Research.

MDI adds McKesson's CareEnhance Disease Monitor software to Viewpoint Analytics solutions portfolio

MDI announced today that it has added McKesson's CareEnhance® Disease Monitor software to the Viewpoint Analytics solutions portfolio. Integrating one of the industry's leading disease management products increases the breadth of solutions available from Viewpoint Analytics.

Study: Pradaxa drug may increase risk and severity of viral infections

A study led by researchers at the University of North Carolina indicates that a newly approved blood thinner that blocks a key component of the human blood clotting system may increase the risk and severity of certain viral infections, including flu and myocarditis, a viral infection of the heart and a significant cause of sudden death in children and young adults.

Read more Medical News

› Verified 8 days ago

Readmission Rate

The rate of readmission show you whether patients who were being treated regularly at Fmc-Balboa East County were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.

Standard Readmission Summary Ratio(SRR) YearJanuary, 2016 - December, 2016
Readmission Rate in facility26.2 (As Expected)
Readmission Rate: Upper Confidence Limit34.7
Readmission Rate: Lower Confidence Limit18.6

News Archive

Drinking piping hot beverages may increase risk of esophagus tumors

Drinking piping hot coffee, tea and the caffeine-infused beverage yerba mate probably causes cancer, the World Health Organization announced Wednesday.

Denosumab effective in treating giant-cell tumor of the bone

Treatment with denosumab, a drug targeted against a protein that helps promote bone destruction, decreased the number of tumor giant cells in patients with giant-cell tumor of the bone, and increased new bone formation, according to the results of a phase II study published in Clinical Cancer Research, a journal of the American Association for Cancer Research.

MDI adds McKesson's CareEnhance Disease Monitor software to Viewpoint Analytics solutions portfolio

MDI announced today that it has added McKesson's CareEnhance® Disease Monitor software to the Viewpoint Analytics solutions portfolio. Integrating one of the industry's leading disease management products increases the breadth of solutions available from Viewpoint Analytics.

Study: Pradaxa drug may increase risk and severity of viral infections

A study led by researchers at the University of North Carolina indicates that a newly approved blood thinner that blocks a key component of the human blood clotting system may increase the risk and severity of certain viral infections, including flu and myocarditis, a viral infection of the heart and a significant cause of sudden death in children and young adults.

Read more Medical News

› Verified 8 days ago

Infection Rate

Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Fmc-Balboa East County get infections in their blood each year compared to the number of infections expected for the center based on the national average.

Standard Infection Summary Ratio(SIR) YearJanuary, 2016 - December, 2016
Infection Rate in facility.75 (As Expected)
SIR: Upper Confidence Limit1.57
SIR: Lower Confidence Limit.31

News Archive

Drinking piping hot beverages may increase risk of esophagus tumors

Drinking piping hot coffee, tea and the caffeine-infused beverage yerba mate probably causes cancer, the World Health Organization announced Wednesday.

Denosumab effective in treating giant-cell tumor of the bone

Treatment with denosumab, a drug targeted against a protein that helps promote bone destruction, decreased the number of tumor giant cells in patients with giant-cell tumor of the bone, and increased new bone formation, according to the results of a phase II study published in Clinical Cancer Research, a journal of the American Association for Cancer Research.

MDI adds McKesson's CareEnhance Disease Monitor software to Viewpoint Analytics solutions portfolio

MDI announced today that it has added McKesson's CareEnhance® Disease Monitor software to the Viewpoint Analytics solutions portfolio. Integrating one of the industry's leading disease management products increases the breadth of solutions available from Viewpoint Analytics.

Study: Pradaxa drug may increase risk and severity of viral infections

A study led by researchers at the University of North Carolina indicates that a newly approved blood thinner that blocks a key component of the human blood clotting system may increase the risk and severity of certain viral infections, including flu and myocarditis, a viral infection of the heart and a significant cause of sudden death in children and young adults.

Read more Medical News

› Verified 8 days ago

Transfusion Summary

Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Fmc-Balboa East County's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.

Standard Transfusion Summary Ratio (STrR) Year January, 2016 - December, 2016
Patients in facility's Transfusion Summary 131
Transfusion Rate in facility31.9 (As Expected)
Transfusion Rate: Upper Confidence Limit62.1
Transfusion Rate: Lower Confidence Limit17.7

News Archive

Drinking piping hot beverages may increase risk of esophagus tumors

Drinking piping hot coffee, tea and the caffeine-infused beverage yerba mate probably causes cancer, the World Health Organization announced Wednesday.

Denosumab effective in treating giant-cell tumor of the bone

Treatment with denosumab, a drug targeted against a protein that helps promote bone destruction, decreased the number of tumor giant cells in patients with giant-cell tumor of the bone, and increased new bone formation, according to the results of a phase II study published in Clinical Cancer Research, a journal of the American Association for Cancer Research.

MDI adds McKesson's CareEnhance Disease Monitor software to Viewpoint Analytics solutions portfolio

MDI announced today that it has added McKesson's CareEnhance® Disease Monitor software to the Viewpoint Analytics solutions portfolio. Integrating one of the industry's leading disease management products increases the breadth of solutions available from Viewpoint Analytics.

Study: Pradaxa drug may increase risk and severity of viral infections

A study led by researchers at the University of North Carolina indicates that a newly approved blood thinner that blocks a key component of the human blood clotting system may increase the risk and severity of certain viral infections, including flu and myocarditis, a viral infection of the heart and a significant cause of sudden death in children and young adults.

Read more Medical News

› Verified 8 days ago

Survival Summary

The rate of mortality show you whether patients who were being treated regularly at Fmc-Balboa East County lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.

Standard Survival Summary Ratio(SIR) YearJanuary, 2013 - December, 2016
Patients in facility's Survival Summary796
Mortality Rate in facility15.8 (As Expected)
Mortality Rate: Upper Confidence Limit19.2
Mortality Rate: Lower Confidence Limit12.8

News Archive

Drinking piping hot beverages may increase risk of esophagus tumors

Drinking piping hot coffee, tea and the caffeine-infused beverage yerba mate probably causes cancer, the World Health Organization announced Wednesday.

Denosumab effective in treating giant-cell tumor of the bone

Treatment with denosumab, a drug targeted against a protein that helps promote bone destruction, decreased the number of tumor giant cells in patients with giant-cell tumor of the bone, and increased new bone formation, according to the results of a phase II study published in Clinical Cancer Research, a journal of the American Association for Cancer Research.

MDI adds McKesson's CareEnhance Disease Monitor software to Viewpoint Analytics solutions portfolio

MDI announced today that it has added McKesson's CareEnhance® Disease Monitor software to the Viewpoint Analytics solutions portfolio. Integrating one of the industry's leading disease management products increases the breadth of solutions available from Viewpoint Analytics.

Study: Pradaxa drug may increase risk and severity of viral infections

A study led by researchers at the University of North Carolina indicates that a newly approved blood thinner that blocks a key component of the human blood clotting system may increase the risk and severity of certain viral infections, including flu and myocarditis, a viral infection of the heart and a significant cause of sudden death in children and young adults.

Read more Medical News

› Verified 8 days ago


Dialysis Facility in El Cajon, CA

Fmc-Rai-Fletcher Parkway-El Cajon
Location: 858 Fletcher Parkway, El Cajon, California, 92020
Phone: (619) 442-4122
Fmc-Balboa East County
Location: 570 N. Second Street, El Cajon, California, 92021
Phone: (619) 588-7500

News Archive

Drinking piping hot beverages may increase risk of esophagus tumors

Drinking piping hot coffee, tea and the caffeine-infused beverage yerba mate probably causes cancer, the World Health Organization announced Wednesday.

Denosumab effective in treating giant-cell tumor of the bone

Treatment with denosumab, a drug targeted against a protein that helps promote bone destruction, decreased the number of tumor giant cells in patients with giant-cell tumor of the bone, and increased new bone formation, according to the results of a phase II study published in Clinical Cancer Research, a journal of the American Association for Cancer Research.

MDI adds McKesson's CareEnhance Disease Monitor software to Viewpoint Analytics solutions portfolio

MDI announced today that it has added McKesson's CareEnhance® Disease Monitor software to the Viewpoint Analytics solutions portfolio. Integrating one of the industry's leading disease management products increases the breadth of solutions available from Viewpoint Analytics.

Study: Pradaxa drug may increase risk and severity of viral infections

A study led by researchers at the University of North Carolina indicates that a newly approved blood thinner that blocks a key component of the human blood clotting system may increase the risk and severity of certain viral infections, including flu and myocarditis, a viral infection of the heart and a significant cause of sudden death in children and young adults.

Read more Medical News

› Verified 8 days ago


Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.